Celltrion
068270.KS
#829
Rank
$27.98 B
Marketcap
$124.44
Share price
0.38%
Change (1 day)
10.96%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): $1.07

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $1.07. In 2023 the company made an earnings per share (EPS) of $2.77 a decrease over its 2022 EPS that were of $2.83.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$1.07
2023$2.77-2.08%
2022$2.83-11.72%
2021$3.202.03%
2020$3.1482.8%
2019$1.7218.31%
2018$1.45-36.33%
2017$2.28161.25%
2016$0.872.86%
2015$0.8517.84%
2014$0.725.87%
2013$0.68-70.85%
2012$2.33134.09%
2011$1.0043.59%
2010$0.6974.49%
2009$0.40317.8%
2008$0.09516-71.7%
2007$0.34